CBFV vs XLV
CBFV: A community-oriented bank holding company providing relationship-based commercial and consumer banking services across southwestern Pennsylvania and West Virginia. XLV: A sector-specific ETF providing broad exposure to companies across the entire U.S. health care landscape, from major pharmaceuticals to medical device manufacturers.
Side-by-side fundamentals
| Metric | CBFV | XLV | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $39.67 | $184.87 | |
| Market cap as of 2026-08-05 (share count; price 2026-10-30) | $202M | n/a | |
| P/E as of 2026-10-30 | 28.96 | n/a | |
| Net margin FY2021, SEC XBRL | +26.6% | n/a | |
| ROE FY2025, SEC XBRL | +3.1% | n/a | |
| ROA FY2025, SEC XBRL | +0.3% | n/a | |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 0.40 | n/a | |
| Revenue CAGR (3y) SEC XBRL | -7.6% | n/a | |
| Dividend yield as of 2026-09-03 | 2.82% | n/a | |
| Dividend streak (yrs) SEC XBRL | 9 | n/a | |
| Beta as of 2026-09-03 | 0.41 | n/a | |
| 1-year return as of 2026-10-30 close | +23.7% | +28.1% | XLV higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.